Los Angeles, CA, United States of America

Nancy E Braverman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nancy E Braverman: Innovator in Zellweger Spectrum Disorder Treatment

Introduction

Nancy E Braverman is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of medical research, particularly in the treatment of Zellweger spectrum disorder (ZSD). Her innovative work has the potential to improve the lives of individuals affected by this rare genetic condition.

Latest Patents

Nancy E Braverman holds a patent for "Compositions and methods for the treatment of Zellweger spectrum disorder." This patent outlines methods for treating ZSD in subjects by administering a therapeutically effective amount of specific compounds. The focus of her research is on improving peroxisome assembly in cells, which is crucial for addressing the underlying issues associated with ZSD.

Career Highlights

Throughout her career, Nancy has demonstrated a commitment to advancing medical science. Her work has not only contributed to the understanding of Zellweger spectrum disorder but has also paved the way for potential therapeutic interventions. With her innovative approach, she has established herself as a key figure in her field.

Collaborations

Nancy has collaborated with notable professionals in her field, including Joseph G Hacia and Patricia Dranchak. These partnerships have enhanced her research efforts and contributed to the development of effective treatment methods for Zellweger spectrum disorder.

Conclusion

Nancy E Braverman's contributions to the treatment of Zellweger spectrum disorder highlight her dedication to medical innovation. Her patent and collaborative efforts reflect her commitment to improving health outcomes for those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…